• Tackling Trial and Data Complexity in DCTs with Advanced Analytics and Machine Learning

    Clinical Research News | Advanced statistical and machine learning (ML) models offer new ways to cope with an evolving and increasingly complex clinical trial data landscape. It enables us to interrogate new, complex and raw data sources, perform complex data reviews, learn from past studies and process large volumes of data.

    Sep 12, 2025

  • The Scope of Things: A Global Movement to Cure Multiple Myeloma

    Clinical Research News | In this month’s episode of The Scope of Things podcast, Joseph Mikhael, chief medical officer of the International Myeloma Foundation (IMF), discusses how the Black Swan Research Initiative (BSRI), a global scientific alliance dedicated to finding a cure for multiple myeloma, and global collaborators are making strides in multiple myeloma research and prevention efforts.

    Sep 10, 2025

  • The Scope of Things: A Global Movement to Cure Multiple Myeloma

    Clinical Research News | In this month’s episode of The Scope of Things podcast, Joseph Mikhael, chief medical officer of the International Myeloma Foundation (IMF), discusses how the Black Swan Research Initiative (BSRI), a global scientific alliance dedicated to finding a cure for multiple myeloma, and global collaborators are making strides in multiple myeloma research and prevention efforts.

    Sep 10, 2025

  • New Microbiome-Derived Proteins Trials for Chronic Disease Treatment

    Clinical Research News | The gut microbiome has long been recognized as a key influencer of human health, but most clinical efforts to translate that knowledge have revolved around broad dietary interventions, probiotics, or microbial metabolites. Now, a team of researchers in Denmark is taking a new route that focuses on specific bacterial proteins that may directly regulate human metabolism and advancing them into clinical testing.

    Sep 9, 2025

  • New Microbiome-Derived Proteins Trials for Chronic Disease Treatment

    Clinical Research News | The gut microbiome has long been recognized as a key influencer of human health, but most clinical efforts to translate that knowledge have revolved around broad dietary interventions, probiotics, or microbial metabolites. Now, a team of researchers in Denmark is taking a new route that focuses on specific bacterial proteins that may directly regulate human metabolism and advancing them into clinical testing.

    Sep 9, 2025

  • LLMs Transform Clinical Trial Data Analysis with Human-Level Accuracy

    Clinical Research News | A study presented at the American Association for Cancer Research (AACR) conference reveals that large language models (LLMs) can match human experts in identifying critical cancer progression events from electronic health records—a development with significant implications for clinical trials and personalized medicine.

    Sep 4, 2025

  • Many Trials Testing Psychedelics for Treating Substance Abuse Disorders

    Clinical Research News | A resurgence of research interest in psychedelics over the past 25 years might soon see compounds like psilocybin, otherwise known as “magic mushrooms,” finally having their day. In the clinical trial setting, dozens of studies are now underway testing psychedelics for the treatment of post-traumatic stress disorder (PTSD), depression, and, perhaps most commonly, substance abuse disorders (SUDs).

    Sep 2, 2025

  • Study Cancellations Undercut Site Viability, Stakeholders Say

    Clinical Research News | In an environment where clinical trial budgets are scrutinized and timelines compressed, the human and operational toll of cancelled studies poses a serious threat. It undercuts site stability, strains patient engagement, and jeopardizes future collaboration. A recent SCOPE 365 ClinEco Connect session convened industry veterans across sites, sponsors, and CROs to seek a solution.

    Aug 28, 2025